2023. Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s272. DOI:https://doi.org/10.25251/skin.7.supp.272.